These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24131460)

  • 21. The association between clinically suspect arthralgia and adipokines in obese patients.
    Kose R; Sargin G; Senturk T; Cildag S; Unubol M; Abas Bİ; Yenisey C
    Acta Reumatol Port; 2018; 43(4):284-290. PubMed ID: 30641537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis.
    Askarpour M; Alizadeh S; Hadi A; Symonds ME; Miraghajani M; Sheikhi A; Ghaedi E
    Horm Metab Res; 2020 Apr; 52(4):207-215. PubMed ID: 32268422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of adipokines with obesity in children and adolescents.
    Jaleel A; Aheed B; Jaleel S; Majeed R; Zuberi A; Khan S; Ahmed B; Shoukat F; Hashim H
    Biomark Med; 2013 Oct; 7(5):731-5. PubMed ID: 24044565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113).
    Indulekha K; Anjana RM; Surendar J; Mohan V
    Clin Biochem; 2011 Mar; 44(4):281-7. PubMed ID: 21219897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum adipokine profiles in Kawasaki disease.
    Kemmotsu Y; Saji T; Kusunoki N; Tanaka N; Nishimura C; Ishiguro A; Kawai S
    Mod Rheumatol; 2012 Feb; 22(1):66-72. PubMed ID: 21633913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splanchnic concentrations and postprandial release of visceral adipokines.
    Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
    Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy.
    Gonzalez-Gay MA; Vazquez-Rodriguez TR; Garcia-Unzueta MT; Berja A; Miranda-Filloy JA; de Matias JM; Gonzalez-Juanatey C; Llorca J
    Clin Exp Rheumatol; 2010; 28(1):56-62. PubMed ID: 20346239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.
    Deng L; Zhao X; Chen M; Ji H; Zhang Q; Chen R; Wang Y
    BMC Endocr Disord; 2020 May; 20(1):63. PubMed ID: 32393372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Adipokines, Inflammatory Markers, and Sex Hormones in Simple and Complex Breast Cysts' Fluid.
    Madej P; Franik G; Kurpas P; Owczarek A; Chudek J; Olszanecka-Glinianowicz M
    Dis Markers; 2016; 2016():5174929. PubMed ID: 27293305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome.
    Hosseinzadeh-Attar MJ; Golpaie A; Foroughi M; Hosseinpanah F; Zahediasl S; Azizi F
    J Endocrinol Invest; 2016 Aug; 39(8):917-22. PubMed ID: 27023106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
    Ciresi A; Amato MC; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamics the level of visfatin and markers of immune inflammation in hypertensive patients with abdominal obesity using the combination of antihypertensive therapy].
    Andreeva AA
    Georgian Med News; 2013 Dec; (225):72-7. PubMed ID: 24423680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.